218 related articles for article (PubMed ID: 15245963)
1. Differential expression of activator protein-2 isoforms in renal cell carcinoma.
Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M
Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963
[TBL] [Abstract][Full Text] [Related]
2. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
[TBL] [Abstract][Full Text] [Related]
3. Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes.
Oyama N; Takahashi H; Tojo M; Iwatsuki K; Iizuka H; Nakamura K; Homma Y; Kaneko F
Arch Dermatol Res; 2002 Aug; 294(6):273-80. PubMed ID: 12192491
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia inducible factor-1alpha and 2alpha in genetically distinct early renal cortical tumors.
Kim CM; Vocke C; Torres-Cabala C; Yang Y; Schmidt L; Walther M; Linehan WM
J Urol; 2006 May; 175(5):1908-14. PubMed ID: 16600797
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional factor AP-2gamma increases human cystatin A gene transcription of keratinocytes.
Takahashi H; Oyama N; Itoh Y; Ishida-Yamamoto A; Kaneko F; Iizuka H
Biochem Biophys Res Commun; 2000 Nov; 278(3):719-23. PubMed ID: 11095974
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer.
Gee JM; Robertson JF; Ellis IO; Nicholson RI; Hurst HC
J Pathol; 1999 Dec; 189(4):514-20. PubMed ID: 10629551
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 expression in kidney tubules adjacent to renal cell carcinoma: evidence of a precursor lesion.
Lai R; el Dabbagh L; Mourad WA
Mod Pathol; 1996 Jun; 9(6):690-5. PubMed ID: 8782209
[TBL] [Abstract][Full Text] [Related]
10. Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosis.
Anastasiadis AG; Lemm I; Radzewitz A; Lingott A; Ebert T; Ackermann R; Ryffel GU; Schulz WA
Anticancer Res; 1999; 19(3A):2105-10. PubMed ID: 10470156
[TBL] [Abstract][Full Text] [Related]
11. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
[TBL] [Abstract][Full Text] [Related]
12. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
Ruiz M; Troncoso P; Bruns C; Bar-Eli M
Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
[TBL] [Abstract][Full Text] [Related]
13. Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
Orso F; Cottone E; Hasleton MD; Ibbitt JC; Sismondi P; Hurst HC; De Bortoli M
Biochem J; 2004 Jan; 377(Pt 2):429-38. PubMed ID: 14565844
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of members of the AP-1 transcriptional factor family from an early stage of renal carcinogenesis and inhibition of cell growth by AP-1 gene antisense oligonucleotides in the Tsc2 gene mutant (Eker) rat model.
Urakami S; Tsuchiya H; Orimoto K; Kobayashi T; Igawa M; Hino O
Biochem Biophys Res Commun; 1997 Dec; 241(1):24-30. PubMed ID: 9405228
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
[TBL] [Abstract][Full Text] [Related]
17. Pax-2 expression in adult renal tumors.
Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
[TBL] [Abstract][Full Text] [Related]
18. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
19. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
[TBL] [Abstract][Full Text] [Related]
20. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
